Works matching IS 0344-5704 AND VI 64 AND IP 1 AND DT 2009

Results: 30

MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.

Published in:

2009

By:

Woodahl EL;
Crouthamel MH;
Bui T;
Shen DD;
Ho RJ;
Woodahl, Erica L;
Crouthamel, Matthew H;
Bui, Tot;
Shen, Danny D;
Ho, Rodney J Y

Publication type:

journal article

Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects.

Published in:

2009

By:

Nalda-Molina R;
Valenzuela B;
Ramon-Lopez A;
Miguel-Lillo B;
Soto-Matos A;
Perez-Ruixo JJ;
Nalda-Molina, Ricardo;
Valenzuela, Belén;
Ramon-Lopez, Amelia;
Miguel-Lillo, Bernardo;
Soto-Matos, Arturo;
Perez-Ruixo, Juan Jose

Publication type:

journal article

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma.

Published in:

2009

By:

Sym SJ;
Lee DH;
Kang HJ;
Nam SH;
Kim HY;
Kim SJ;
Eom HS;
Kim WS;
Suh C

Publication type:

Journal Article

Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 53, doi. 10.1007/s00280-008-0850-3

By:

Hoch, Ute;
Lynch, Jennifer;
Sato, Yuji;
Kashimoto, Shigeki;
Kajikawa, Fumie;
Furutani, Yasuji;
Silverman, Jeffrey A.

Publication type:

Article

Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 161, doi. 10.1007/s00280-008-0861-0

By:

Kim, Kevin B.;
Wen-Jen Hwu;
Papadopoulos, Nicholas E.;
Bedikian, Agop Y.;
Camacho, Luis H.;
Chaan Ng;
Hernandez, Ingrid M.;
Frost, Angela M.;
Jack, Monica A.;
Hwu, Patrick

Publication type:

Article

Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 153, doi. 10.1007/s00280-008-0857-9

By:

Otaegui, Dorleta;
Rodríguez-Gascón, Alicia;
Zubia, Aizpea;
Cossío, Fernando P.;
Pedraz, José Luis

Publication type:

Article

Role of copper transporters in resistance to platinating agents.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 133, doi. 10.1007/s00280-008-0860-1

By:

Rabik, Cara A.;
Maryon, Edward B.;
Kasza, Kristen;
Shafer, John T.;
Bartnik, Catherine M.;
Dolan, M. Eileen

Publication type:

Article

Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 115, doi. 10.1007/s00280-008-0856-x

By:

Ekhart, Corine;
Rodenhuis, Sjoerd;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Population pharmacokinetics meta-analysis of plitidepsin (Aplidin<sup>®</sup>) in cancer subjects.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 97, doi. 10.1007/s00280-008-0841-4

By:

Nalda-Molina, Ricardo;
Valenzuela, Belén;
Ramon-Lopez, Amelia;
Miguel-Lillo, Bernardo;
Soto-Matos, Arturo;
Perez-Ruixo, Juan

Publication type:

Article

Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 79, doi. 10.1007/s00280-008-0845-0

By:

Kolesar, Jill;
Wei Huang;
Eickhoff, Jens;
Hahn, Kristine;
Alberti, Dona;
Attia, Steven;
Schelman, William;
Holen, Kyle;
Traynor, Anne;
Ivy, Percy;
Wilding, George

Publication type:

Article

Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 35, doi. 10.1007/s00280-008-0842-3

By:

Harmsen, S.;
Meijerman, I.;
Beijnen, J. H.;
Schellens, J. H. M.

Publication type:

Article

Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 177, doi. 10.1007/s00280-008-0900-x

By:

Bharthuar, Anubha;
Egloff, Lori;
Becker, Joanne;
George, Marina;
Lohr, James W.;
Deeb, George;
Iyer, Renuka V.

Publication type:

Article

MDR1 ( ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 183, doi. 10.1007/s00280-008-0906-4

By:

Woodahl, Erica L.;
Crouthamel, Matthew H.;
Bui, Tot;
Shen, Danny D.;
Ho, Rodney J. Y.

Publication type:

Article

Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form.

Published in:

2009

By:

Shin, Beom;
Kim, Hyoung;
Hong, Seok;
Lee, Jong;
Hwang, Sang;
Lee, Mann;
Yoo, Sun

Publication type:

Correction Notice

Topoisomerase I involvement in schedule-dependent interaction between 5-fluoro-uracil and irinotecan in the treatment of colorectal cancer.

Published in:

2009

By:

Richter, Sara N.;
Nadai, Matteo;
Palumbo, Manlio;
Palù, Giorgio

Publication type:

Letter

Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs?

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 201, doi. 10.1007/s00280-009-0976-y

By:

Thomasset, Sarah;
Teller, Nicole;
Hong Cai;
Marko, Doris;
Berry, David P.;
Steward, William P.;
Gescher, Andreas J.

Publication type:

Article

Matrix metalloproteinases: key regulators in the pathogenesis of chemotherapy-induced mucositis?

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 1, doi. 10.1007/s00280-009-0984-y

By:

Al-Dasooqi, Noor;
Gibson, Rachel J.;
Bowen, Joanne M.;
Keefe, Dorothy M.

Publication type:

Article

Anticancer activities of sesquiterpene lactones from Cyathocline purpurea in vitro.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 143, doi. 10.1007/s00280-008-0863-y

By:

Guoyi Ma;
Li Chong;
Zuqiang Li;
Cheung, Andrew H. T.;
Tattersall, Martin H. N.

Publication type:

Article

Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.

Published in:

2009

By:

Beauchesne, Patrick D.;
Taillandier, L.;
Bernier, V.;
Carnin, C.

Publication type:

Report

To widen the setting of cancer patients who could benefit from metronomic capecitabine.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 189, doi. 10.1007/s00280-009-0930-z

By:

Nannini, Margherita;
Nobili, Elisabetta;
Di Cicilia, Roberto;
Brandi, Giovanni;
Maleddu, Alessandra;
Pantaleo, Maria A.;
Biasco, Guido

Publication type:

Article

Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 195, doi. 10.1007/s00280-008-0905-5

By:

Breccia, Massimo;
Frustaci, Anna Maria;
Cannella, Laura;
Soverini, Simona;
Stefanizzi, Caterina;
Federico, Vincenzo;
Grammatico, Sara;
Santopietro, Michelina;
Alimena, Giuliana

Publication type:

Article

Treatment of metastatic renal cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 11, doi. 10.1007/s00280-009-0983-z

By:

Reeves, David J.;
Liu, Chin Y.

Publication type:

Article

Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 67, doi. 10.1007/s00280-008-0852-1

By:

Bajetta, Emilio;
Di Bartolomeo, Maria;
Buzzoni, Roberto;
Ferrario, Erminia;
Dotti, Katia F.;
Mariani, Luigi;
Bajetta, Roberto;
Gevorgyan, Arpine;
Venturino, Paola;
Galassi, Margherita

Publication type:

Article

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 73, doi. 10.1007/s00280-008-0846-z

By:

Mori, Kiyoshi;
Kobayashi, Hiroyuki;
Kamiyama, Yukari;
Kano, Yasuhiko;
Kodama, Tetsuro

Publication type:

Article

Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 87, doi. 10.1007/s00280-008-0849-9

By:

Beom Soo Shin;
Hyoung Jun Kim;
Seok Hyun Hong;
Jong Bong Lee;
Sang Wook Hwang;
Mann Hyung Lee;
Sun Dong Yoo

Publication type:

Article

Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 109, doi. 10.1007/s00280-008-0851-2

By:

Kanayama, Masahiro;
Nagai, Hidenari;
Sumino, Yasukiyo

Publication type:

Article

Irinotecan-induced mucositis is associated with changes in intestinal mucins.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 123, doi. 10.1007/s00280-008-0855-y

By:

Stringer, Andrea M.;
Gibson, Rachel J.;
Logan, Richard M.;
Bowen, Joanne M.;
Yeoh, Ann S. J.;
Laurence, Jessica;
Keefe, Dorothy M. K.

Publication type:

Article

Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report.

Published in:

2009

By:

Mitamura, Takashi;
Hosaka, Masayoshi;
Takeda, Mahito;
Watari, Hidemichi;
Sakuragi, Noriaki

Publication type:

Report

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 27, doi. 10.1007/s00280-008-0847-y

By:

Sun Jin Sym;
Dae Ho Lee;
Hye Jin Kang;
Seung Hyun Nam;
Ho Young Kim;
Seok Jin Kim;
Hyeon Seok Eom;
Won Seog Kim;
Cheolwon Suh

Publication type:

Article

Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 45, doi. 10.1007/s00280-008-0844-1

By:

Attia, Steven;
Morgan-Meadows, Sherry;
Holen, Kyle D.;
Bailey, Howard H.;
Eickhoff, Jens C.;
Schelman, William R.;
Traynor, Anne M.;
Mulkerin, Daniel L.;
Campbell, Toby C.;
McFarland, Thomas A.;
Huie, Michael S.;
Cleary, James F.;
Tevaarwerk, Amye J.;
Alberti, Dona B.;
Wilding, George;
Liu, Glenn

Publication type:

Article